REFERENCES
- American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). Washington, DC: Author.
- Balon, R., & Segraves, R. T. (2016). Which emperor has new clothes? Biology versus psychology in the era of statistical magic. Journal of Sex & Marital Therapy. Advance online publication.
- Bancroft, J. (2009). Human sexuality and its problems (3rd ed.). Edinburgh: Churchill Livingstone.
- Barlow, D. H., Gorman, J. M., Shear, M. K., & Woods, S. W. (2000). Cognitive-behavioral therapy, imipramine, or their combination for panic disorder: A randomized controlled trial. JAMA, 283, 2529–2536.
- Bradford, A., & Meston, C. M. (2009). Placebo response in the treatment of women's sexual dysfunctions: A review and commentary. Journal of Sex & Marital Therapy, 35, 164–181.
- Brotto, L. A., Basson, R., Chivers, M. L., Graham, C. A., Pollock, P., & Stephenson, K. R. (2016). Challenges in designing psychological treatment studies for sexual dysfunction. Journal of Sex & Marital Therapy. Advance online publication.
- Clayton, A. H., & Pyke, P. E. (2016). Standards in Studies of Psychotherapy and Pharmacotherapy Interventions for HSDD. Journal of Sex & Marital Therapy. Advance online publication. http://dx.doi.org/10.1080/0092623X.2016.1217296
- Foa, E. B., & Kozak, M. J. (1986). Emotional processing of fear: Exposure to corrective information. Psychological Bulletin, 99, 20–35. doi:10.1037/0033-2909.99.1.20
- Frühauf, S., Gerger, H., Schmidt, H. M., Munder, T., & Barth, J. (2013). Efficacy of psychological interventions for sexual dysfunction: A systematic review and meta-analysis. Archives of Sexual Behavior, 42, 915–933.
- Gao, Z., Yang, D., Yu, L., & Cui, Y. (2015). Efficacy and safety of flibanserin in women with hypoactive sexual desire disorder: A systematic review and meta‐analysis. The Journal of Sexual Medicine, 12, 2095–2104. doi:10.1111/jsm.13037
- Goldfischer, E. R., Breaux, J., Katz, M., Kaufman, J., Smith, W. B., Kimura, T., & Pyke, R. (2011). Continued efficacy and safety of flibanserin in premenopausal women with hypoactive sexual desire disorder (HSDD): Results from a randomized withdrawal trial. The Journal of Sexual Medicine, 8(11), 3160–3170. doi:10.1111/j.1743-6109.2011.02458.x
- Hofmann, S. G., Wu, J. Q., & Boettcher, H. (2014). Effect of cognitive-behavioral therapy for anxiety disorders on quality of life: A meta-analysis. Journal of Consulting and Clinical Psychology, 82, 375–391. doi:10.1037/a0035491
- Jaspers, L., Feys, F., Bramer, W. M., Franco, O. H., Leusink, P., & Laan, E. T. (2016). Efficacy and safety of flibanserin for the treatment of hypoactive sexual desire disorder in women: A systematic review and meta-analysis. JAMA Internal Medicine, 176, 453–462.
- Laan, E. T., Jaspers, L., & Leusink, P. (2016). Appropriate perspective and context for newly approved medications, including flibanserin—Reply. JAMA Internal Medicine, 176, 1404–1405.
- Lindsay, D. S. (2015). Replication in psychological science. Psychological Science, 26, 1827–1832.
- Murphy, M. J., Mermelstein, L. C., Edwards, K. M., & Gidycz, C. A. (2012). The benefits of dispositional mindfulness in physical health: A longitudinal study of female college students. Journal of American College Health, 60, 341–348. doi:10.1080/07448481.2011.629260
- Pyke, R. E., Clayton, A. H. (2015). Psychological treatment trials for hypoactive sexual desire disorder: A sexual medicine critique and perspective. Journal of Sexual Medicine, 12, 2451–2458.
- Sullivan, G. M., & Feinn, R. (2012). Using effect size—or why the P value is not enough. Journal of Graduate Medical Education, 4(3), 279–282.
- Tiefer, L. (2016). Apples and oranges: “Sexual Medicine” and the effort to deny that counting and classifying are political acts. Journal of Sex & Marital Therapy. Advance online publication. http://dx.doi.org/10.1080/0092623X.2016.1230162
- U.S. Food and Drug Administration. (2015). Flibanserin Advisory Committee Briefing Document. (2015). Retrieved from http://www.fda.gov/downloads/advisorycommittees/committeesmeetingmaterials/drugs/drugsafetyandriskmanagementadvisorycommittee/ucm449090.pdf
- Wakefield, J. C. (1992). Disorder as harmful dysfunction: A conceptual critique of DSM-III-R's definition of mental disorder. Psychological Review, 99, 232–247.